BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 19902306)

  • 21. Phenol as an adjuvant for local control in the treatment of giant cell tumour of the bone.
    Dürr HR; Maier M; Jansson V; Baur A; Refior HJ
    Eur J Surg Oncol; 1999 Dec; 25(6):610-8. PubMed ID: 10556009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Beneficial effects of cryosurgical treatment in benign and low-grade-malignant bone tumors in 120 patients].
    Schreuder HW; Keijser LC; Veth RP
    Ned Tijdschr Geneeskd; 1999 Nov; 143(45):2275-81. PubMed ID: 10578429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Features of grade 3 giant cell tumors of the distal radius associated with successful intralesional treatment.
    Kang L; Manoso MW; Boland PJ; Healey JH; Athanasian EA
    J Hand Surg Am; 2010 Nov; 35(11):1850-7. PubMed ID: 20934816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Malignant giant-cell tumours of bone. Clinico-pathological types and prognosis: a review of 29 cases.
    Anract P; De Pinieux G; Cottias P; Pouillart P; Forest M; Tomeno B
    Int Orthop; 1998; 22(1):19-26. PubMed ID: 9549577
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does Denosumab Change the Giant Cell Tumor Treatment Strategy? Lessons Learned From Early Experience.
    Agarwal MG; Gundavda MK; Gupta R; Reddy R
    Clin Orthop Relat Res; 2018 Sep; 476(9):1773-1782. PubMed ID: 30794215
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The outcome of surgical treatment for recurrent giant cell tumor in the appendicular skeleton.
    Wan R; Zhang W; Xu J; Hao P; Yang Y; Shen Y; Ding X; Qiu S
    J Orthop Sci; 2012 Jul; 17(4):464-9. PubMed ID: 22526715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Giant cell tumor of bone in children and adolescents.
    Puri A; Agarwal MG; Shah M; Jambhekar NA; Anchan C; Behle S
    J Pediatr Orthop; 2007 Sep; 27(6):635-9. PubMed ID: 17717462
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary malignant giant cell tumour of bone--a study of two cases with short review.
    Mondal A; Kundu R; Chatterjee J
    Indian J Pathol Microbiol; 2000 Oct; 43(4):403-7. PubMed ID: 11344602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Giant cell tumour of bone in the appendicular skeleton: an analysis of 276 cases.
    Xing R; Yang J; Kong Q; Tu C; Zhou Y; Duan H
    Acta Orthop Belg; 2013 Dec; 79(6):731-7. PubMed ID: 24563982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The outcomes of treatment of giant cell tumor of bone around the knee.
    Asavamongkolkul A; Eamsobhana P; Waikakul S; Phimolsarnti R
    J Med Assoc Thai; 2012 Sep; 95 Suppl 9():S122-8. PubMed ID: 23326994
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surgical treatment and prognostic factors in giant-cell tumor of bone.
    Szendröi M; Kiss J; Antal I
    Acta Chir Orthop Traumatol Cech; 2003; 70(3):142-50. PubMed ID: 12882097
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytokine and cytokine receptor serum levels in adult bone sarcoma patients: correlations with local tumor extent and prognosis.
    Rutkowski P; Kamińska J; Kowalska M; Ruka W; Steffen J
    J Surg Oncol; 2003 Nov; 84(3):151-9. PubMed ID: 14598359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The choice strategy of surgical treatment for giant cell tumor close to the knee].
    Yang ZM; Tao HM; Yang DS; Ye ZM; Li WX
    Zhonghua Wai Ke Za Zhi; 2006 Dec; 44(24):1693-8. PubMed ID: 17359718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary malignant giant cell tumor of bone: a series of three rare cases.
    Kapoor SK; Jain V; Agrawal M; Singh S; Mandal AK
    J Surg Orthop Adv; 2007; 16(2):89-92. PubMed ID: 17592717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Argon beam coagulation as an adjuvant for local control of giant cell tumor.
    Lewis VO; Wei A; Mendoza T; Primus F; Peabody T; Simon MA
    Clin Orthop Relat Res; 2007 Jan; 454():192-7. PubMed ID: 16957652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The influence of adjuvants on local recurrence rate in giant cell tumour of the bone.
    Pietschmann MF; Dietz RA; Utzschneider S; Baur-Melnyk A; Jansson V; Dürr HR
    Acta Chir Belg; 2010; 110(6):584-9. PubMed ID: 21337837
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recurrence of curetted and bone-grafted giant-cell tumours with and without adjuvant phenol therapy.
    Trieb K; Bitzan P; Lang S; Dominkus M; Kotz R
    Eur J Surg Oncol; 2001 Mar; 27(2):200-2. PubMed ID: 11289759
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Local recurrence of giant cell tumor of bone after intralesional treatment with and without adjuvant therapy.
    ; Becker WT; Dohle J; Bernd L; Braun A; Cserhati M; Enderle A; Hovy L; Matejovsky Z; Szendroi M; Trieb K; Tunn PU
    J Bone Joint Surg Am; 2008 May; 90(5):1060-7. PubMed ID: 18451399
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Intralesional curettage and wide excision for treatment of giant cell tumors (GCTs) of the distal radius: A Meta-analysis].
    Yin ZC; Liu BG; Pang QJ; Chen XJ; Yu X
    Zhongguo Gu Shang; 2016 Jan; 29(1):58-64. PubMed ID: 27019899
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Higher local recurrence rates after intralesional surgery for giant cell tumor of the proximal femur compared to other sites.
    Errani C; Tsukamoto S; Leone G; Akahane M; Cevolani L; Tanzi P; Kido A; Honoki K; Tanaka Y; Donati DM
    Eur J Orthop Surg Traumatol; 2017 Aug; 27(6):813-819. PubMed ID: 28589498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.